MDS, the Toronto-based parent company of Canadian medical isotope supplier MDS Nordion, reported that its Life Sciences division, which includes MDS Nordion, had fiscal 2003 fourth-quarter revenues of $275 million, Canadian ($207.2 million) a downturn from the $283 million, CAD ($213.2 million) posted for the same period in 2002.